These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3877562)

  • 21. Circulating immune complexes in patients with malignant lymphomas and solid tumors.
    Heier HE; Carpentier N; Lange G; Lambert PH; Godal T
    Int J Cancer; 1977 Dec; 20(6):887-94. PubMed ID: 338514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serial measurement of circulating immune complexes in healthy subjects.
    Puskás E; Füst G; Angyal I; Nguyen-Chi-Phi ; Gergely J
    Immunol Lett; 1982 Apr; 4(4):223-7. PubMed ID: 6807843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating antigen-antibody complexes in onchocerciasis.
    Steward MW; Sisley B; Mackenzie CD; El Sheikh H
    Clin Exp Immunol; 1982 Apr; 48(1):17-24. PubMed ID: 6979445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating immune complexes correlate with remission duration in acute myeloid leukemia.
    Larson RA; Lukin CL; Daly KM; Mick R; Gore S; Le Beau MM
    Leukemia; 1991 Feb; 5(2):131-7. PubMed ID: 2020195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of pathologic and normal sera by immune complex determination: five disease groups within 190 samples are discriminated by computer-selected combinations of 13 methods. Report of the Italian committee for the study of immune complexes (WIC).
    Migliorini P; Aiuti F; Balestrieri G; Bombardieri S; Cantarella S; Carbonara A; Clerici E; Coppo R; Cordiali Fei P; D'Amelio R
    Clin Immunol Immunopathol; 1984 Sep; 32(3):298-315. PubMed ID: 6235997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in circulating immune complexes in tumour patient serum after in vitro or ex vivo affinity chromatography of blood plasma or whole blood over immunoglobulin-binding staphylococcal protein A-Sepharose.
    Håkansson L; Hed J; Baldetorp L; Eneström S; Jonsson S; Liedén G
    Int J Artif Organs; 1984 Jan; 7(1):23-6. PubMed ID: 6365797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
    Krieger G; Kneba M; Bolz I; Volling P; Wessels J; Nagel GA
    J Clin Lab Immunol; 1985 Nov; 18(3):129-34. PubMed ID: 3878887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
    Rossen RD; Crane MM; Morgan AC; Giannini EH; Giovanella BC; Stehlin JS; Twomey JJ; Hersh EM
    Cancer Res; 1983 Jan; 43(1):422-9. PubMed ID: 6600161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating immune complexes in the sera and ascites of hepatocellular carcinoma or chronic hepatitis patients.
    Chen YM; Hu CP; Wong FH; Chen PH; Tsai YT; Lee SD; Liu JD; Chang CM
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Feb; 19(1):34-45. PubMed ID: 3028719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial measurement of circulating immune complexes in the sera of patients with leukaemia.
    Mód A; Carpentier N; Füst G; Lambert PH; Miescher P; Hollán SR
    J Clin Lab Immunol; 1980 Jul; 4(1):15-20. PubMed ID: 7007648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between clinical disease, circulating antibodies and C1q-binding immune complexes in human onchocerciasis.
    Sisley BM; Mackenzie CD; Steward MW; Williams JF; O'Day J; Luty AJ; Braga M; el Sheikh H
    Parasite Immunol; 1987 Jul; 9(4):447-63. PubMed ID: 3498141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
    Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
    J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating immune complexes and prognosis in human malignant lymphoma, a prospective study.
    Heier HE; Landaas TO; Marton PF
    Int J Cancer; 1979 Mar; 23(3):292-8. PubMed ID: 437911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo reduction of circulating C1q binding immune complexes by intravenous gammaglobulin administration.
    Lin RY; Racis SP
    Int Arch Allergy Appl Immunol; 1986; 79(3):286-90. PubMed ID: 2419257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactivity of low molecular weight material in cellular immune complex assays.
    Cooper KM; Moore M
    Clin Exp Immunol; 1983 May; 52(2):407-16. PubMed ID: 6602679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Circulating immune complexes in breast cancer].
    Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
    Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating immune complexes in regularly dialyzed patients with chronic renal failure.
    Perez GO; Glasson P; Favre H; Wauters JP; Benzonana G; Jeannet M; Lambert PH
    Am J Nephrol; 1984; 4(4):215-21. PubMed ID: 6236693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating immune complexes in cervical cancer patients as detected by C1q binding.
    Chao KC; Liu CC; Ng HT; Hu CP; Chang CM
    Proc Natl Sci Counc Repub China B; 1984 Jan; 8(1):50-3. PubMed ID: 6335756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating immune complexes (CIC) in Hodgkin's disease. I. Levels and two-dimensional analysis.
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1989; 36(2):199-205. PubMed ID: 2716924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.